Floatz logo

Therapeutic Asset Ratings

181 results matching 1 filter

129,767 assets · 8,707 sponsors · 3,128 indications
Methodology v0.2
AssetSponsorPhaseRating
APG 2449
Non-Small Cell Lung Carcinoma
Ascentage Pharma Group Inc.P1C (37)
Astx727
Non-Small Cell Lung Carcinoma
Royal Marsden NHS Foundation TrustP1C (37)
aur106
Non-Small Cell Lung Carcinoma
Aurigene Discovery Technologies LimitedP1C (37)
azd1390
Non-Small Cell Lung Carcinoma
University of LeedsP1C (37)
Bl-M17D1
Non-Small Cell Lung Carcinoma
SystImmune Inc.P1C (37)
Bl-M24D1
Non-Small Cell Lung Carcinoma
Sichuan Baili Pharmaceutical Co., Ltd.P1C (37)
Clsp-5282
Non-Small Cell Lung Carcinoma
Clasp Therapeutics, Inc.P1C (37)
cs08399
Non-Small Cell Lung Carcinoma
Chipscreen Biosciences, Ltd.P1C (37)
Ctx-8371
Non-Small Cell Lung Carcinoma
Compass TherapeuticsP1C (37)
dk210
Non-Small Cell Lung Carcinoma
DEKA BiosciencesP1C (37)
dr-0202
Non-Small Cell Lung Carcinoma
Dren BioP1C (37)
Emapalumab
Non-Small Cell Lung Carcinoma
Nerissa T. ViolaP1C (37)
Emunkitug
Non-Small Cell Lung Carcinoma
HiFiBiO TherapeuticsP1C (37)
Etakafusp Alfa
Non-Small Cell Lung Carcinoma
Asher Biotherapeutics, Inc.P1C (37)
ft536
Non-Small Cell Lung Carcinoma
Fate TherapeuticsP1C (37)
Hbi-2376
Non-Small Cell Lung Carcinoma
HUYABIO International, LLC.P1C (37)
Hbi-2438
Non-Small Cell Lung Carcinoma
HUYABIO International, LLC.P1C (37)
hc-7366
Non-Small Cell Lung Carcinoma
HiberCell, Inc.P1C (37)
Hekt Cell
Non-Small Cell Lung Carcinoma
Ruijin HospitalP1C (37)
hfb200603
Non-Small Cell Lung Carcinoma
HiFiBiO TherapeuticsP1C (37)
Icovamenib
Non-Small Cell Lung Carcinoma
Biomea Fusion Inc.P1C (37)
ide034
Non-Small Cell Lung Carcinoma
IDEAYA BiosciencesP1C (37)
kk2269
Non-Small Cell Lung Carcinoma
Kyowa Kirin Co., Ltd.P1C (37)
lm103
Non Small Cell Lung Cancer
Suzhou BlueHorse Therapeutics Co., Ltd.P1C (37)
Mem-288 Intratumoral
Non-Small Cell Lung Carcinoma
Memgen, Inc.P1C (37)
Showing 126 to 150 of 181 assets
PreviousPage 6 of 8Next